CIAM
ELDN icon

Caitong International Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Caitong International Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426 Buy
108
+107
+10,700% +$389 ﹤0.01% 1790
2026
Q1 		$3 Buy
+1
New +$2 ﹤0.01% 2370

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Caitong International Asset Management's ELDN Position: Q2 2026 in Review

Caitong International Asset Management increased its Eledon Pharmaceuticals (ELDN) stake by 10,700% in Q2 2026, buying an estimated $389 and bringing the position to 108 shares worth $426. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Caitong International Asset Management first reported a position in ELDN in Q1 2026 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Caitong International Asset Management held 108 shares of Eledon Pharmaceuticals worth $426 as of Q2 2026.
  • Caitong International Asset Management bought 107 Eledon Pharmaceuticals shares in Q2 2026, an estimated $389.
  • Eledon Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1790 holding.
  • Caitong International Asset Management first reported a position in Eledon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.